Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: islet cell transplant therapy - Islet Sciences

Drug Profile

Research programme: islet cell transplant therapy - Islet Sciences

Alternative Names: Encapsulated porcine islet cells - Islet Sciences; Islet cells encapsulated with ultra-pure algae membrane - Islet Sciences; Islet Sciences-P; ISLT-P; PTM therapy - Islet Sciences

Latest Information Update: 16 Jul 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Islet Sciences
  • Class Cell therapies
  • Mechanism of Action Pancreatic beta cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Type 1 diabetes mellitus

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Type-1 diabetes mellitus in USA (Intra-abdominal, Injection)
  • 30 Sep 2014 Islet Sciences and BHV Pharma enter into a definitive merger agreement ,
  • 27 Jun 2013 Dr Jonathan Lakey (Islet Sciences) receives $US1.27 million in funding from Juvenile Diabetes Research Foundation to support development of innovative methods to treat Type 1 diabetes mellitus, including its islet cell transplantation therapy

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top